Cargando…
Liposomal extended-release bupivacaine for postsurgical analgesia
When physicians consider which analgesia to use postsurgery, the primary goal is to relieve pain with minimal adverse side effects. Bupivacaine, a commonly used analgesic, has been formulated into an aqueous suspension of multivesicular liposomes that provide long-lasting analgesia for up to 72 hour...
Autores principales: | Lambrechts, Mark, O’Brien, Michael J, Savoie, Felix H, You, Zongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772762/ https://www.ncbi.nlm.nih.gov/pubmed/24043932 http://dx.doi.org/10.2147/PPA.S32175 |
Ejemplares similares
-
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia
por: Bergese, Sergio D, et al.
Publicado: (2012) -
Economic Outcomes and Incidence of Postsurgical Hypotension With Liposomal Bupivacaine vs Epidural Analgesia in Abdominal Surgeries
por: Holtz, Margaret, et al.
Publicado: (2022) -
Infiltration of liposome bupivacaine into the transversus abdominis plane for postsurgical analgesia in robotic laparoscopic prostatectomy: a pilot study
por: Sternlicht, Andrew, et al.
Publicado: (2014) -
Hyaluronan Does Not Affect Bupivacaine's Inhibitory Action on Voltage-Gated Potassium Channel Activities in Bovine Articular Chondrocytes
por: Hester, William, et al.
Publicado: (2012) -
Safety of liposome extended-release bupivacaine for postoperative pain control
por: Portillo, Juan, et al.
Publicado: (2014)